MSA
MEDP icon

Mason Street Advisors’s Medpace MEDP Stock Holding History

Mason Street Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-14,711
Closed -$2.05M – 737
2020
Q4 		$2.05M Buy
14,711
+119
+0.8% +$15K 0.03% 619
2020
Q3 		$1.63M Buy
14,592
+4,499
+45% +$520K 0.03% 617
2020
Q2 		$939K Buy
10,093
+555
+6% +$47.2K 0.02% 840
2020
Q1 		$700K Hold
9,538
– – 0.02% 866
2019
Q4 		$802K Buy
9,538
+326
+4% +$25.2K 0.02% 974
2019
Q3 		$774K Buy
9,212
+484
+6% +$36.6K 0.02% 949
2019
Q2 		$571K Buy
8,728
+361
+4% +$20.8K 0.01% 1052
2019
Q1 		$493K Buy
8,367
+340
+4% +$20.3K 0.01% 1144
2018
Q4 		$425K Buy
+8,027
New +$441K 0.01% 1090

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mason Street Advisors's MEDP Position: Q1 2021 in Review

Mason Street Advisors sold out of Medpace (MEDP) in Q1 2021, closing a stake of 14,711 shares — an estimated $2.05M sold.

Mason Street Advisors first reported a position in MEDP in Q4 2018 and held it in 9 quarters. The position peaked at $2.05M in Q4 2020. 319 funds tracked by Wall St. Rank hold MEDP as of Q1 2021.

  • Mason Street Advisors reported no remaining Medpace position as of Q1 2021 after selling out during the quarter.
  • Mason Street Advisors sold 14,711 Medpace shares in Q1 2021, an estimated $2.05M.
  • Mason Street Advisors first reported a position in Medpace in Q4 2018 and held it in 9 quarters.
  • Mason Street Advisors's Medpace position peaked at $2.05M in Q4 2020.
  • 319 funds tracked by Wall St. Rank held Medpace as of Q1 2021.

Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.